[CTLT] Catalent, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 2.96 B

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 26.9 Change: 0.56 (2.13%)
Ext. hours: Change: 0 (0%)

chart CTLT

Refresh chart

Strongest Trends Summary For CTLT

CTLT is in the medium-term up 35% in 1 year. In the long-term up 97% in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through three segments: Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segment?s oral dose forms include soft gel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development & Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scient

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding124.71 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -14.05% Sales Growth - Q/Q-2.02% P/E
P/E To EPS Growth P/S1.61 P/BV6.33 Price/Cash Per Share
Price/Free Cash Flow53.01 ROA2.88% ROE18.13% ROI3.43%
Current Ratio1.79 Quick Ratio1.4 Long Term Debt/Equity6.45 Debt Ratio0.77
Gross Margin33.9% Operating Margin14.77% Net Profit Margin4.66% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities209 M Cash From Investing Activities-240.3 M Cash From Operating Activities94.7 M Gross Profit152.2 M
Net Profit31.5 M Operating Profit65.8 M Total Assets2.97 B Total Current Assets653.1 M
Total Current Liabilities365.4 M Total Debt1.88 B Total Liabilities2.51 B Total Revenue446.6 M
Technical Data
High 52 week58.05 Low 52 week29.84 Last close49.2 Last change1.78%
RSI47.88 Average true range1.05 Beta1.08 Volume419.58 K
Simple moving average 20 days0.56% Simple moving average 50 days-5.07% Simple moving average 200 days6.17%
Performance Data
Performance Week3.14% Performance Month-2.73% Performance Quart-8.48% Performance Half15.6%
Performance Year18.64% Performance Year-to-date57.79% Volatility daily1.53% Volatility weekly3.41%
Volatility monthly6.99% Volatility yearly24.22% Relative Volume271.85% Average Volume747.83 K
New High New Low

News

2019-11-10 05:54:38 | 3 Monster Growth Stocks That Are Still Undervalued

2019-11-05 08:55:01 | Catalent CTLT Surpasses Q1 Earnings and Revenue Estimates

2019-11-05 07:30:00 | Catalent, Inc. Reports First Quarter Fiscal 2020 Results

2019-11-04 11:23:04 | Drug/Biotech Stocks Nov 5 Earnings Roster: AGN, REGN & More

2019-10-31 03:00:00 | Cycle Pharmaceuticals and Catalent Partner to Develop Treatments for Rare Diseases Using Zydis ODT Technology

2019-10-30 12:57:56 | Ken Fisher's Top 5 Buys for the 3rd Quarter

2019-10-30 07:28:09 | The Catalent NYSE:CTLT Share Price Has Gained 125%, So Why Not Pay It Some Attention?

2019-10-29 10:33:02 | Earnings Preview: Catalent CTLT Q1 Earnings Expected to Decline

2019-10-28 09:30:01 | CTLT vs. NBIX: Which Stock Should Value Investors Buy Now?

2019-10-17 14:49:54 | Paragon growing quickly toward 1,000 employees after Catalent acquisition

2019-10-17 10:11:02 | Aurinia Pharmaceuticals AUPH Catches Eye: Stock Jumps 6.2%

2019-10-14 20:10:27 | Is Catalent Inc CTLT A Good Stock To Buy?

2019-10-10 09:30:01 | CTLT or NBIX: Which Is the Better Value Stock Right Now?

2019-10-09 16:15:00 | Catalent, Inc. Announces First Quarter Fiscal Year 2020 Earnings Conference Webcast

2019-10-07 10:03:19 | Is Catalent, Inc.'s NYSE:CTLT High P/E Ratio A Problem For Investors?

2019-09-13 08:34:14 | Does Catalent NYSE:CTLT Have A Healthy Balance Sheet?

2019-09-06 09:40:01 | JAZZ vs. CTLT: Which Stock Is the Better Value Option?

2019-09-04 09:15:01 | Lannett LCI Hits 52-Week High, Can the Run Continue?

2019-09-02 09:00:01 | Catalent CTLT Upgraded to Buy: Here's Why

2019-08-30 08:48:44 | Edited Transcript of CTLT earnings conference call or presentation 27-Aug-19 12:15pm GMT

2019-08-28 14:42:17 | Catalent Analyst Cites Valuation Concerns In Downgrade

2019-08-27 16:20:24 | This Surging Medical Stock Beats Views, But Shares Take A Breather

2019-08-27 12:23:29 | Catalent Inc CTLT Q4 2019 Earnings Call Transcript

2019-08-27 08:55:12 | Catalent CTLT Surpasses Q4 Earnings and Revenue Estimates

2019-08-27 07:48:02 | Catalent Reports Q4 Earnings Beat

2019-08-27 07:30:00 | Catalent, Inc. Reports Fourth Quarter Fiscal 2019 Results

2019-08-26 14:35:13 | Catalent's Q4 Earnings Outlook

2019-08-26 13:13:03 | What Are Analysts Saying About Catalent, Inc.'s NYSE:CTLT Growth?

2019-08-21 06:11:09 | Read This Before Judging Catalent, Inc.'s NYSE:CTLT ROE

2019-08-20 10:30:02 | Earnings Preview: Catalent CTLT Q4 Earnings Expected to Decline

2019-08-19 10:10:02 | Medtronic MDT to Post Q1 Earnings: Will RTG Aid the Stock?

2019-08-16 10:49:02 | Medtronic MDT to Report Q1 Earnings: What's in Store?

2019-08-09 10:42:02 | Tilray TLRY to Report Q2 Earnings: What's in the Cards?

2019-08-07 18:32:20 | Novavax looks to next flu vaccine trial following sale of manufacturing business

2019-07-31 10:10:02 | Why Catalent CTLT is Poised to Beat Earnings Estimates Again

2019-07-24 14:45:36 | 10 Small-Cap, Up-And-Coming Stocks to Keep on Your Radar

2019-07-17 16:15:00 | Catalent, Inc. Announces Fourth Quarter Fiscal Year 2019 Earnings Conference Webcast

2019-07-15 09:30:01 | CTLT vs. ZTS: Which Stock Is the Better Value Option?

2019-07-12 13:42:00 | Here's Why Catalent Stock Soared 73.9% in the First Half of 2019

2019-07-09 07:00:00 | Catalent Extends Global Commercial Spray Drying Capabilities in Europe

2019-06-27 07:00:00 | Novavax selling manufacturing business amid good news for flu vaccine

2019-06-24 14:56:00 | Catalent Announces Pricing of Private Offering of Senior Unsecured Notes Due 2027

2019-06-24 14:03:08 | Catalent Pharma Solutions, Inc. -- Moody's assigns B3 rating to Catalent's notes offering

2019-06-24 07:24:00 | Catalent Announces Launch of Private Offering of $500 Million of Senior Unsecured Notes Due 2027

2019-06-23 16:10:53 | Did Hedge Funds Drop The Ball On Catalent Inc CTLT ?

2019-06-19 09:00:01 | Catalent CTLT Upgraded to Buy: What Does It Mean for the Stock?

2019-06-19 06:59:00 | Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy

2019-06-10 08:06:38 | See what the IHS Markit Score report has to say about Catalent Inc.

2019-05-30 16:15:00 | Catalent, Inc. to Present at the Jefferies Healthcare Conference

2019-05-30 08:04:59 | See what the IHS Markit Score report has to say about Catalent Inc.